Organon Executive and Leadership Team

Mazen Altaruti, the President, Emerging Markets (Japan) at Organon, spearheads the company's strategic expansion and operational execution within key international markets, with a specific focus on Japan. Altaruti directs the commercial and market access strategies tailored to the unique healthcare landscape of emerging economies. This leadership role involves fostering business partnerships and leveraging Organon's innovative prescription medicines to address critical health needs. By driving growth and ensuring product availability, Altaruti plays a crucial part in Organon's global mission to improve the health and quality of human life. The President's oversight ensures that Organon effectively navigates regional complexities and maximizes its impact in these vital territories.

Jo Snyder, the Chief of Staff at Organon, directs critical operational initiatives and strategic planning to advance the company's mission of improving human health. Snyder oversees the coordination of cross-functional teams, ensuring alignment with Organon's core therapeutic fields and business objectives. This leadership position involves managing key projects and facilitating communication between executive leadership and various departments. By optimizing internal processes and driving strategic execution, Snyder ensures that Organon effectively leverages its innovation and business partnerships. The Chief of Staff's role is pivotal in translating high-level strategy into actionable plans, thereby supporting the company's market presence and commitment to quality.

Manav Maheshwari, the Chief Information Officer, Strategic Business Planning Lead, Digital & Commercial Strategy at Organon, architects the company's technological infrastructure and digital transformation initiatives. Maheshwari drives the strategic business planning process, ensuring that Organon's operations are optimized for efficiency and innovation. This dual role encompasses developing and executing digital and commercial strategies that enhance market reach and patient access to vital medicines. By integrating cutting-edge technology with robust business planning, Maheshwari supports Organon's objective to leverage its core therapeutic fields. The Chief Information Officer's leadership ensures that digital capabilities are central to Organon's growth and its mission to improve human life through innovative prescription medicines.

Michael Casia, the Interim Head of Commercial & Government Affairs (US) at Organon, directs the company's commercial operations and government relations within the United States. Casia oversees the strategic deployment of Organon's innovative prescription medicines, ensuring they reach patients and healthcare providers effectively. This critical role involves managing key relationships with government bodies and stakeholders to advocate for patient access and support Organon's business objectives. By aligning commercial strategies with public health priorities, Casia drives market penetration and reinforces Organon's commitment to improving human life. The Interim Head's leadership ensures Organon's significant presence and impact within the US healthcare ecosystem.